MedPath

Saphmirate-T50

Brand Name: Saphmirate-T50

Generic Name: Butamirate Citrate

Active
Registration Number

DRP-9828

Dosage Form

Sustained-Release Tablet

Issuance Date

April 2, 2025

Expiry Date

April 2, 2030

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50 mg
PackagingAlu Foil Strip x 4's (Box of 4's, 40's and 100's) Alu Foil Strip x 10's (Box of 40's and 100's)

Classification

C
Classification
Over-the-Counter (OTC) Drug
P
Pharmacologic
Angiotensin II Receptor Blocker (ARB)
A
Application
Initial (Variation)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Butamirate CitrateActive
Monograph: Butamirate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.